UHRF1 and osteosarcoma: Inducible UHRF1 KO (iKO) and inducible VC (iVC) osteosarcoma cells were subcutaneously injected, and tumors allowed to establish for one week before inducing Cas9 expression via oral doxycycline delivery (Fig. 2D).